Alexander Cherkassky

Liquid Chromatography-Mass Spectrometry Market Size Expands

man in white chef suit standing in front of white and red plastic bottles

A clinical product development senior executive, Alexander Cherkassky of Massachusetts holds an MBA in technology management from the New York Institute of Technology and serves as senior director and franchise head at Fluidigm, Inc. Alexander Cherkassky worked at PerkinElmer, Inc., where he oversaw the development of clinical mass spectrometry-based solutions. Furthermore, he has filed several patent applications in clinical microbiology using liquid chromatography-mass spectrometry (LC-MS).

Liquid chromatography-mass spectrometry is used in food production, pharmaceutical, biotech, cosmetics, and other sectors to evaluate biological, renewable, and inorganic components from samples. The worldwide LC-MS market was roughly $3,683.7 million in 2019, with a CAGR of 12.0 percent over the forecast period.

The worldwide liquid chromatography-mass spectrometry market is projected to grow as the healthcare industry invests more in research and development. With a share of over 55 percent, the United States is the largest LC-MS market. Due to a rise in product launches and the adoption of inorganic development methods in North America, the region dominates the worldwide LC-MS market. The Asia Pacific and Europe markets are next on the list with an aggregate share of roughly 35 percent.

Genetic Newborn Screenings Tests

Alexander Cherkassky is a vice president with Fluidigm Inc. Previously, he served as a platform director for Thermo Fisher Scientific and as R&D director for PerkinElmer in Massachusetts. Alongside his firm, Alexander Cherkassky helps develop genetic newborn screenings that detect certain health conditions and can potentially save the life of a child.

Newborn screenings are health services offered to all children at birth in the US. Through these screenings, doctors can detect whether the baby has rare, genetic, or hormone-related conditions that wouldn’t otherwise be found until later stages of life. The screening consists of a blood sample that is taken about 24 hours after the birth of the baby. The results of the tests usually come in a couple of days, but there are also tests for hearing loss or heart disease that provide the result right away.

If any test is positive, it does not necessarily mean that the baby is infected or has a health condition. The baby is then sent for further testing to a physician specializing in the suspected condition. If a condition is detected, it’s often critical that treatment be implemented as soon as possible. This may include special formula, supplements, diet restrictions, medicines, and monitoring.

Liverpool FC’s Oustanding Honors List

With a BS in biochemistry from Northeastern University and an MS in bioinformatics from Boston University in Boston, Massachusetts, Alexander Cherkassky is a senior director and franchise head at Fluidigm, Inc. When he is not working, Alexander Cherkassky enjoys playing soccer and watching the English Premier League. His favorite team is Liverpool FC.

Liverpool is one of the most accomplished football clubs in the Premier League, with an impressive 48 major team honors. Starting from the top Premier League honors, Liverpool has won 19 league titles, including the 2019-20 title under manager Jurgen Klopp. It was the first time the club won the title in 30 years and a well-deserved title given how the team played well and stayed ahead of the pack all through the season. Many of the other titles on the club’s cabinet were won in the 1970s and ‘80s.

Outside the Premier League, Liverpool has won six European Cups, the highest number for a British team, with their most recent win occurring in the 2018-19 season. Later that year, the club won its first FIFA Club World Cup in 2019 with a victory over Monterrey and Flamengo in Qatar. Liverpool has also won seven FA Cups, three UEFA Cups, four UEFA Super Cups, and 15 Charity/Community Shields.

Fluidigm’s Non-Invasive, High-Capacity COVID-19 Test

A resident of Wayland, Massachusetts, Alexander Cherkassky is a project leader with years of experience in the biotechnology and diagnostics industry. A senior director and franchise head at Fluidigm, Alexander Cherkassky provides leadership over the development of life science tools to visualize over 30 cellular parameters.

Following the appearance of COVID-19 in 2020, Fluidigm marshaled its team and resources to develop a safe, fast, and convenient way to test people for SARS-CoV-2, the virus behind COVID-19. The company developed Advanta Dx SARS-CoV-2 RT-PCR Assay, a qPCR-based test that enabled high-capacity tests of saliva samples from patients suspected of having the virus.

The test leveraged the company’s proprietary microfluidics technology to support rapid testing for effective diagnostic decision-making. Unlike the nasal tests that came before it, Fluidigm’s assay was non-invasive, making it easier to collect samples. It also had lower sample volume requirements (only 15uL of saliva) and could test as many as 6,000 samples a day.

The assay was approved for use by the FDA under its Emergency Use Authorization, and to allow the public easier access to the test, Fluidigm launched Community Connect to connect organizations with certified labs offering it.

Liverpool FC and Other European Super League Clubs Commit to UEFA Play

An experienced senior business administrator with a history in biochemistry and bioinformatics, Massachusetts resident Alexander Cherkassky leads the mass cytometry and spatial tissue imaging organization Fluidigm. When he isn’t working, Alexander Cherkassky closely follows Premier League soccer and his favorite team, Liverpool FC.

Since the premature dissolution of the European Super League, Liverpool FC and the eight other former members of this enormously unpopular offshoot league have demonstrated a firm commitment to returning to play as part of the Union of European Football Associations and its affiliated organizations. To deter the formation of future breakaway leagues, all European Super League clubs have agreed to pay fines if they pursue any unauthorized play. They have also agreed to a 5 percent garnishing of their seasonal revenues in 2023 and 2024. Last but certainly not least, former European Super League teams will contribute a total of 15 million euros to fund youth and grassroots football programs throughout Europe.

Screen4Rare Aims to Improve Access to Newborn Screenings in Europe

A graduate of Boston University and Northeastern University, Alexander Cherkassky holds broad experience in the life sciences and diagnostic business management. Alexander Cherkassky currently resides in Wayland, Massachusetts, where he serves as senior director and franchise head of spatial tissue imaging and mass cytometry at Fluidigm Corporation. He maintains membership in professional organizations such as the International Society of Newborn Screening (ISNS).

Committed to promoting and advancing life-saving screenings for babies, the ISNS takes an active interest in policies related to newborn screening worldwide. The organization works closely with international organizations such as the International Patient Organization for Primary Immunodeficiencies (IPOPI) to promote the value of newborn health screenings as part of the European Union’s health policy agenda. Specifically, ISNS and IPOPI advocate for equitable access to newborn screens for families across Europe, encouraging the creation of appropriate public health programs aligned with the needs of each country’s populations.

This collaborative framework, known as Screen4Rare, aims to increase the rates of life-saving interventions for newborns by making screenings a routine part of postnatal care.

ASMS Conference on Mass Spectrometry Postponed to October 2021

A researcher and mass spectrometry professional, Alexander Cherkassky has more than 20 years of experience in the bioinformatics industry. He earned his master’s degree in the subject from Northeastern University and Boston University in Massachusetts. Since 2018, Alexander Cherkassky has served as a senior director at Fluidigm Inc. He is also a member of the American Society for Mass Spectrometry (ASMS).

The American Society for Mass Spectrometry (ASMS) was founded in 1969. It functions as a nonprofit organization that promotes knowledge of mass spectrometry, in addition to related scientific topics. ASMS holds an annual conference focusing on mass spectrometry where scientists present and discuss their research papers. The 69th ASMS Conference on Mass Spectrometry and Allied Topics will be held October 31 through November 4, 2021, at the Philadelphia Convention Center. The event was originally scheduled during June, but was postponed until late October to boost the chances of a face-to-face event.

This year’s conference will include more than 60 oral sessions chaired by some of the most prominent figures in the academic and scientific community, including Novartis associate director Jennifer Campbell and senior scientist at Institut Pasteur Julia Chamot-Rooke. The topics to be discussed during the oral sessions range from drug research to artificial intelligence in mass spectrometry. Oral sessions are organized in two sets of eight on the last four days of the five-day event .

Tips to Maintain a Workout Routine While Traveling

For more than 20 years, Alexander Cherkassky has worked as a leader and manager in the health sciences industry. Before starting his current position as a senior director at Fluidigm, he was platform director of clinical and medical devices at Thermo Fisher Scientific in Waltham, Massachusetts. When not occupied with his duties, Alexander Cherkassky enjoys playing and watching soccer, exercising, and travel.

People who travel extensively often struggle to maintain an exercise routine, due to the time and distance from their gym. If this is the case and the hotel has no fitness room with equipment, pack running shoes, resistance bands, a foldable yoga mat, or a jump rope, since these are easy to transport.

Another way to stay active during trips is to pick exercises that do not require equipment or leaving the lodging. Use calisthenics and yoga techniques, do push-ups, lunges, and sit-ups, or try Pilates. It is easy to find items that can work as weights in the hotel room, or use a chair for chair dips.

For those who enjoy working out with other people, search online for a local class, such as spin or dance class.

American Society for Microbiology’s Agar Art Competition

A resident of Massachusetts, Alexander Cherkassky has been the senior director of product management, spatial tissue imaging, and mass cytometry at Fluidigm Inc. since 2018. As part of his professional development, Alexander Cherkassky is a member of many groups and organizations, including the American Society for Microbiology (ASM).

The American Society for Microbiology hosts an annual agar art competition as part of its public outreach. Agar art is art created in a petri dish with living microorganisms. Since 2015, ASM has encouraged artists and scientists alike to “paint” with bacteria, carefully handling microbes such as E. coli, staph, and salmonella to literally bring their visions to life.

In 2018, a category to feature agar art by kids was added. Children as young as 5 have placed and are featured on ASM’s website. Also in 2018, the main category was split into a professionals category and a makers category. Professionals include professional, graduate, and undergraduate bioartists as well as life scientists and students of the life sciences. All other adults submitting agar art fall into the makers category. First place for each category wins a $200 gift card and ASM credit or merchandise.

The 2020 agar art competition opens for submissions in September.